ClinConnect ClinConnect Logo
Search / Trial NCT06474195

Cue-based Intervention in Prospective Memory and Medication Adherence.

Launched by UNIVERSITY OF PITTSBURGH · Jun 18, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Adherence Schizophrenia Cue Based

ClinConnect Summary

This clinical trial is looking at ways to help people with schizophrenia remember to take their medications regularly. Sometimes, patients forget to take their medicine, which can make it harder for them to manage their condition. In this study, researchers will provide participants with reminders based on time and events to see if this helps improve their memory and, in turn, their ability to stick to their medication schedule.

To join the study, participants need to be between 18 and 60 years old and must have a diagnosis of schizophrenia. They should also have a certain level of understanding about their condition and have completed at least 10th grade in English. Unfortunately, people with serious medical problems, substance abuse issues, or certain learning disabilities won't be able to take part. Those who join can expect to receive support through reminders and will help researchers learn more about how to improve medication adherence for individuals with schizophrenia.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and Female age 18 - 60 years
  • Diagnosed with Schizophrenia as per DSM V Criteria
  • Insight of grade 3 or more.
  • At least 10th standard level of education in the English language
  • Exclusion Criteria:
  • Comorbid chronic medical illnesses.
  • Psychoactive substance use in harmful use pattern or in dependence pattern.
  • Co-existing neurodevelopmental disorders or learning disorders.

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Bengaluru, Karnataka, India

Patients applied

0 patients applied

Trial Officials

Vishwajit L Nimgaonkar, MD, PhD

Principal Investigator

University of Pittburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported